GlassScriptPhysician profile
Jonathan Gandhi
NPI 1568806784
$36,023.68
in general payments reported to CMS, 2019-2025
18 companies · $2,078 in 2025
The $2,078 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $739 · 2020: $5,246 · 2021: $17K · 2022: $3,765 · 2023: $2,168 · 2024: $4,979 · 2025: $2,078.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,049 · Travel and Lodging: $2,177.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,048.60 |
| Travel and Lodging | $2,176.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $27,526.15 | 2020-2025 | Watchman Access System, Farapulse, Watchman Flx |
| Medtronic, INC. | $3,764.41 | 2021-2025 | Micra, Cobalt Dr Mri Surescan, Arctic Front Advance |
| Abbott Laboratories | $3,014.83 | 2019-2025 | Ensite, Aveir |
| Biotronik INC. | $452.49 | 2021 | |
| Medtronic Vascular, INC. | $228.08 | 2019 | |
| Janssen Pharmaceuticals, INC | $190.58 | 2024 | Xarelto |
| Biosense Webster, INC. | $188.94 | 2024-2025 | Carto 3, Nuvision Ice Catheter |
| E.R. Squibb & Sons, L.L.C. | $134.35 | 2022-2023 | Camzyos |
| Astrazeneca Pharmaceuticals LP | $130.53 | 2019-2022 | |
| Abiomed | $130.13 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $54.73 | 2022-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $44.08 | 2023-2024 | |
| Acutus Medical, INC. | $40.27 | 2022 | |
| Pfizer INC. | $38.40 | 2019-2024 | |
| Novo Nordisk INC | $34.29 | 2023 | Ozempic |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $20.50 | 2025 | Atriclip Laa Exclusion System |
| Sanofi-Aventis U.S. LLC | $15.50 | 2024 | |
| Amgen INC. | $15.42 | 2023 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Gandhi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.